KIWA BIO-TECH PRODUCTS GROUP CORP: 10-Q filed 2014-08-19

Name: KIWA BIO-TECH PRODUCTS GROUP CORP: 10-Q filed 2014-08-19
Creator: KIWA BIO-TECH PRODUCTS GROUP CORP

What KIWA BIO-TECH PRODUCTS GROUP CORP reported in its quarterly report filed 2014-08-19 (fiscal Q2 2014): 24 published measures, 70 facts as tagged in accession 0001144204-14-051184.

This filing

Form: 10-Q (quarterly report)
Filed: 2014-08-19
Fiscal period: fiscal Q2 2014
Accession: 0001144204-14-051184 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All KIWA BIO-TECH PRODUCTS GROUP CORP filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2014-06-30	34,879	USD
At 2013-12-31	28,485	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2014-06-30	10,451,811	USD
At 2013-12-31	10,336,049	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2014-06-30	-10,416,932	USD
At 2013-12-31	-10,307,564	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2014-06-30	11,259	USD
At 2013-12-31	2,039	USD
At 2013-06-30	4,934	USD
At 2012-12-31	4,493	USD

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Unit	Days
2014-04-01 to 2014-06-30	USD	91
2014-01-01 to 2014-06-30	USD	181
2013-04-01 to 2013-06-30	USD	91
2013-01-01 to 2013-06-30	USD	181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2014-06-30	-18,288,342	USD
At 2013-12-31	-17,990,598	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Unit	Days
2014-04-01 to 2014-06-30	USD	91
2014-01-01 to 2014-06-30	USD	181
2013-04-01 to 2013-06-30	USD	91
2013-01-01 to 2013-06-30	USD	181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2014-06-30	9,480	USD
At 2013-12-31	11,955	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	-125,938	USD	91
2014-01-01 to 2014-06-30	-253,287	USD	181
2013-04-01 to 2013-06-30	-129,583	USD	91
2013-01-01 to 2013-06-30	-262,216	USD	181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2014-06-30	25,399	USD
At 2013-12-31	16,530	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	5,844	USD	91
2014-01-01 to 2014-06-30	11,906	USD	181
2013-04-01 to 2013-06-30	62,011	USD	91
2013-01-01 to 2013-06-30	123,636	USD	181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2014-06-30	8,598,048	USD
At 2013-12-31	8,436,384	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2014-06-30	313,902	USD
At 2013-12-31	321,670	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	125,938	USD	91
2014-01-01 to 2014-06-30	253,287	USD	181
2013-04-01 to 2013-06-30	129,583	USD	91
2013-01-01 to 2013-06-30	262,216	USD	181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	40,122	USD	91
2014-01-01 to 2014-06-30	81,089	USD	181
2013-04-01 to 2013-06-30	40,620	USD	91
2013-01-01 to 2013-06-30	80,795	USD	181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2014-06-30	400,000,000	shares
At 2013-12-31	400,000,000	shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2014-06-30	-621,927	USD
At 2013-12-31	-810,303	USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

Period	Value	Unit	Days
At 2014-06-30	0	USD
At 2013-12-31	0	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	-148,296	USD	91
2014-01-01 to 2014-06-30	-297,744	USD	181
2013-04-01 to 2013-06-30	-356,093	USD	91
2013-01-01 to 2013-06-30	-711,203	USD	181

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	-148,296	USD	91
2014-01-01 to 2014-06-30	-297,744	USD	181
2013-04-01 to 2013-06-30	-356,093	USD	91
2013-01-01 to 2013-06-30	-711,203	USD	181

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	-164,396	USD	91
2014-01-01 to 2014-06-30	-109,368	USD	181
2013-04-01 to 2013-06-30	-443,541	USD	91
2013-01-01 to 2013-06-30	-821,127	USD	181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	85,816	USD	91
2014-01-01 to 2014-06-30	172,198	USD	181
2013-04-01 to 2013-06-30	88,963	USD	91
2013-01-01 to 2013-06-30	181,421	USD	181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2014-01-01 to 2014-06-30	2,175	USD	181
2013-01-01 to 2013-06-30	2,210	USD	181

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2014-01-01 to 2014-06-30	0	USD	181
2013-01-01 to 2013-06-30	0	USD	181

Inspect the source

Entity: KIWA BIO-TECH PRODUCTS GROUP CORP / CIK 0001159275
Captured: 2026-09-22 19:41 UTC
SEC response SHA-256: 074c7ef0a833d858f3545ca8e68cbd9838b9689e73d55bfdb4b8ce50c68f0c88

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001159275.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))